Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer

Abstract Background Based on their renal excretion, direct oral anticoagulants (DOACs) may increase the risk of hematuria in patients with atrial fibrillation (AF) and urologic cancer compared with vitamin K antagonists. Objectives To examine the risk of bleeding associated with DOAC versus warfarin...

Full description

Bibliographic Details
Main Authors: Anne Gulbech Ording, Mette Søgaard, Flemming Skjøth, Erik Lerkevang Grove, Gregory Y. H. Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
atrial fibrillation
hematuria
urologic neoplasms
warfarin
Online Access:https://doi.org/10.1002/rth2.12629

Internet

https://doi.org/10.1002/rth2.12629

Similar Items